Results 21 to 30 of about 1,099 (157)

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study

Arthritis &Rheumatology, Volume 74, Issue 12, Page 1943-1958, December 2022., 2022
Objective To assess the long‐term safety, tolerability, and efficacy of bimekizumab in patients with active ankylosing spondylitis (AS). Methods Patients with active AS who completed the dose‐ranging, 48‐week BE AGILE randomized controlled trial were eligible to participate in an open‐label extension (OLE) study, in which patients received 160 mg of ...
Xenofon Baraliakos, Atul Deodhar, Maxime Dougados, Lianne S. Gensler, Anna Molto, Sofia Ramiro, Alan J. Kivitz, Denis Poddubnyy, Marga Oortgiesen, Thomas Vaux, Carmen Fleurinck, Julie Shepherd‐Smith, Christine de la Loge, Natasha de Peyrecave, Désirée van der Heijde   +14 more
wiley   +1 more source

Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index

Arthritis Research & Therapy, 2023
Background Physical function is an important determinant of health-related quality of life in radiographic axial spondyloarthritis patients (r-axSpA).
Magnus Hallström, Eva Klingberg, Anna Deminger, Jeannette Beckman Rehnman, Mats Geijer, Helena Forsblad-d’Elia   +5 more
doaj   +1 more source

Validity and feasibility of remote measurement systems for functional movement and posture assessments in people with axial spondylarthritis

Healthcare Technology Letters, Volume 9, Issue 6, Page 110-118, December 2022., 2022
This article introduced and evaluated the validity of a new artificial intelligence‐driven method of automatically analysing a range of standard clinical functional tests. Remote technology systems in rehabilitation have the potential to reduce health inequality and improve cost and time effectiveness for both patients and the health system.
Erin Hannink, Maedeh Mansoubi, Neil Cronin, Benjamin Wilkins, Ali A. Najafi, Benjamin Waller, Helen Dawes   +6 more
wiley   +1 more source

Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study

ACR Open Rheumatology, Volume 4, Issue 9, Page 794-801, September 2022., 2022
Objective Tumor necrosis factor inhibitors (TNFi) are an effective treatment for non‐radiographic axial spondyloarthritis (nr‐axSpA). To be eligible, however, many authorities require patients with nr‐axSpA to show active sacroiliitis on magnetic resonance imaging (MRI) and/or an elevated C‐reactive protein (CRP) level, possibly resulting in a ...
Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul Deodhar   +10 more
wiley   +1 more source

GUIDELINES FOR THE ASSESSMENT OF DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE

Научно-практическая ревматология, 2017
The paper gives the recommendations for the assessment of disease activity and functional status in patients with ankylosing spondylitis in clinical practice, which have been developed by experts, by taking into account international and Russian ...
T. V. Dubinina, I. Z. Gaidukova, A. A. Godzenko, S. A. Lapshina, A. P. Rebrov, O. A. Rumyantseva, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. I. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. V. Smirnov, A. V. Sitalo, Sh. F. Erdes   +18 more
doaj   +1 more source

Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study

Rheumatology and Therapy, 2020
Introduction The aim of this work is to investigate the improvement of physical function and its determinants in axial spondyloarthritis (SpA) patients treated with tumor necrosis factor (TNF) inhibitors in a real clinical practice setting.
Ennio Lubrano, Fabio Massimo Perrotta, Maria Manara, Salvatore D’Angelo, Roberta Ramonda, Leonardo Punzi, Olga Addimanda, Carlo Salvarani, Antonio Marchesoni   +8 more
doaj   +1 more source

Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time‐Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From the German Spondyloarthritis Inception Cohort

Arthritis &Rheumatology, Volume 74, Issue 9, Page 1515-1523, September 2022., 2022
Objective To investigate the longitudinal association between radiographic sacroiliitis progression and treatment with tumor necrosis factor inhibitors (TNFi) in patients with early axial spondyloarthritis (SpA) in a long‐term inception cohort. Methods We included patients from the German Spondyloarthritis Inception Cohort who underwent radiographic ...
Murat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy   +9 more
wiley   +1 more source

The course of ankylosing spondylitis during pregnancy: intermediate data of a prospective follow-up

Современная ревматология, 2019
The onset of ankylosing spondylitis (AS) more frequently occurs at the end of the third decade of life, which corresponds to the time of marriage and the birth of the first child and determines the relevance of a study of the interaction of AS and ...
O. A. Krichevskaya, Z. M. Gandaloeva, A. B. Demina, T. V. Dubinina   +3 more
doaj   +1 more source

Increased proportions of inflammatory T cells and their correlations with cytokines and clinical parameters in patients with ankylosing spondylitis from northern Sweden

Scandinavian Journal of Immunology, Volume 96, Issue 3, September 2022., 2022
Abstract Ankylosing spondylitis (AS) is an autoimmune disease affecting parts of the skeletal structure in particular. Previously increased levels of the inflammatory cell types Th17, Th22, Tc17 and Tc22 cells have been shown to be associated with AS.
Kristina Lejon, Urban Hellman, Lan Do, Anjani Kumar, Helena Forsblad‐d’Elia   +4 more
wiley   +1 more source

Air PDAM Basmi Corona

, 2020
Mengapa air PDAM? Karena air PDAM berisi klor. Disinfeksinya menggunakan kaporit (kalsium hipoklorit, Ca(OCl)2) atau bleaching powder atau puyer kelantang atau chlorinated lime. Setelah diinjeksikan atau dibubuhkan ke dalam air di reservoir, kisaran waktu kontaknya (t, time) antara 15 - 30 menit. Dosis klor antara 0,2 - 40 mg/l. Keuntungannya, ada sisa
openaire   +2 more sources